These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Neurological damage in MSUD: the role of oxidative stress. Sitta A; Ribas GS; Mescka CP; Barschak AG; Wajner M; Vargas CR Cell Mol Neurobiol; 2014 Mar; 34(2):157-65. PubMed ID: 24220995 [TBL] [Abstract][Full Text] [Related]
31. Acute exposure to leucine modifies behavioral parameters and cholinergic activity in zebrafish. Wessler LB; Farias HR; Ronsani JF; Candiotto G; Dos Santos PCL; de Oliveira J; Rico EP; Streck EL Int J Dev Neurosci; 2019 Nov; 78():222-226. PubMed ID: 31589917 [TBL] [Abstract][Full Text] [Related]
32. Treatment of maple syrup urine disease: Benefits, risks, and challenges of liver transplantation. Deon M; Guerreiro G; Girardi J; Ribas G; Vargas CR Int J Dev Neurosci; 2023 Oct; 83(6):489-504. PubMed ID: 37340513 [TBL] [Abstract][Full Text] [Related]
33. Metabolism of branched-chain amino acids in maple syrup urine disease. Schadewaldt P; Wendel U Eur J Pediatr; 1997 Aug; 156 Suppl 1():S62-6. PubMed ID: 9266218 [TBL] [Abstract][Full Text] [Related]
34. Brain Branched-Chain Amino Acids in Maple Syrup Urine Disease: Implications for Neurological Disorders. Xu J; Jakher Y; Ahrens-Nicklas RC Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050626 [TBL] [Abstract][Full Text] [Related]
35. Successful pregnancy in maple syrup urine disease: a case report and review of the literature. Grünert SC; Rosenbaum-Fabian S; Schumann A; Schwab KO; Mingirulli N; Spiekerkoetter U Nutr J; 2018 May; 17(1):51. PubMed ID: 29753318 [TBL] [Abstract][Full Text] [Related]